Symptom control trials: A 20-year experience

Charles L. Loprinzi; Debra L. Barton; Aminah Jatoi; Jeff Sloan; Jim Martenson; David Steensma; Ravi Rao; Paul Novotny; Amit Sood; Axel Grothey; Lori Minasian; Harold Windschitl

Symptom control trials: A 20-year experience

Charles L. Loprinzi, Debra L. Barton, Aminah Jatoi, Jeff Sloan, Jim Martenson, David Steensma, Ravi Rao, Paul Novotny, Amit Sood, Axel Grothey, Lori Minasian, Harold Windschitl

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

Abstract

Symptoms related to cancer and/or cancer therapy are a prominent consideration in cancer patients; multiple options have been proposed to alleviate these problems. The US National Cancer Institute (NCI) Community Clinical Oncology Program (CCOP) has mandated that CCOP participant institutions be involved with cancer control trials in addition to cancer treatment trials. Through such efforts, scientifically sound symptom control clinical trials are being conducted to determine the effectiveness of promising agents. In this article, the authors provide an update of clinical trial outcomes regarding 13 symptom and symptom complexes related to cancer and/or cancer therapy, emphasizing that publication of both positive and negative study results is important to separate what works from what does not.

Original language	English (US)
Pages (from-to)	119-125+128
Journal	Journal of Supportive Oncology
Volume	5
Issue number	3
State	Published - Mar 2007

ASJC Scopus subject areas

Oncology
Pharmacology (medical)

Cite this

@article{c660fdc1c9fc4ae9a993aa35ef8a2c93,

title = "Symptom control trials: A 20-year experience",

abstract = "Symptoms related to cancer and/or cancer therapy are a prominent consideration in cancer patients; multiple options have been proposed to alleviate these problems. The US National Cancer Institute (NCI) Community Clinical Oncology Program (CCOP) has mandated that CCOP participant institutions be involved with cancer control trials in addition to cancer treatment trials. Through such efforts, scientifically sound symptom control clinical trials are being conducted to determine the effectiveness of promising agents. In this article, the authors provide an update of clinical trial outcomes regarding 13 symptom and symptom complexes related to cancer and/or cancer therapy, emphasizing that publication of both positive and negative study results is important to separate what works from what does not.",

author = "Loprinzi, {Charles L.} and Barton, {Debra L.} and Aminah Jatoi and Jeff Sloan and Jim Martenson and David Steensma and Ravi Rao and Paul Novotny and Amit Sood and Axel Grothey and Lori Minasian and Harold Windschitl",

year = "2007",

month = mar,

language = "English (US)",

volume = "5",

pages = "119--125+128",

journal = "Journal of Supportive Oncology",

issn = "1544-6794",

publisher = "Biolink Communications, Inc.",

number = "3",

}

TY - JOUR

T1 - Symptom control trials

T2 - A 20-year experience

AU - Loprinzi, Charles L.

AU - Barton, Debra L.

AU - Jatoi, Aminah

AU - Sloan, Jeff

AU - Martenson, Jim

AU - Steensma, David

AU - Rao, Ravi

AU - Novotny, Paul

AU - Sood, Amit

AU - Grothey, Axel

AU - Minasian, Lori

AU - Windschitl, Harold

PY - 2007/3

Y1 - 2007/3

N2 - Symptoms related to cancer and/or cancer therapy are a prominent consideration in cancer patients; multiple options have been proposed to alleviate these problems. The US National Cancer Institute (NCI) Community Clinical Oncology Program (CCOP) has mandated that CCOP participant institutions be involved with cancer control trials in addition to cancer treatment trials. Through such efforts, scientifically sound symptom control clinical trials are being conducted to determine the effectiveness of promising agents. In this article, the authors provide an update of clinical trial outcomes regarding 13 symptom and symptom complexes related to cancer and/or cancer therapy, emphasizing that publication of both positive and negative study results is important to separate what works from what does not.

AB - Symptoms related to cancer and/or cancer therapy are a prominent consideration in cancer patients; multiple options have been proposed to alleviate these problems. The US National Cancer Institute (NCI) Community Clinical Oncology Program (CCOP) has mandated that CCOP participant institutions be involved with cancer control trials in addition to cancer treatment trials. Through such efforts, scientifically sound symptom control clinical trials are being conducted to determine the effectiveness of promising agents. In this article, the authors provide an update of clinical trial outcomes regarding 13 symptom and symptom complexes related to cancer and/or cancer therapy, emphasizing that publication of both positive and negative study results is important to separate what works from what does not.

UR - http://www.scopus.com/inward/record.url?scp=34249089533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249089533&partnerID=8YFLogxK

M3 - Review article

C2 - 17410810

AN - SCOPUS:34249089533

SN - 1544-6794

VL - 5

SP - 119-125+128

JO - Journal of Supportive Oncology

JF - Journal of Supportive Oncology

IS - 3

ER -

Symptom control trials: A 20-year experience

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this